Carl Icahn, the Chairman of the Board at Icahn Enterprises L.P., is a veteran activist investor with a history dating back to 1980. He's focused his investments on pharmaceutical and biotech firms engaged in cancer vaccine development. Notably, Icahn has supported major players like Advaxis in advancing cancer vaccine research and development.